Editorial: New perspectives in the treatment of myasthenia gravis.

Cortés-Vicente, Elena; Schreiner, Bettina; Saccà, Francesco; Narayanaswami, Pushpa

Cortés-Vicente, Elena; Schreiner, Bettina; Saccà, Francesco; Narayanaswami, Pushpa.

Afiliación

Cortés-Vicente E; Unitat de Malalties Neuromusculars, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Schreiner B; Department of Neurology, University Hospital Zurich, Zürich, Switzerland.
Saccà F; Department of Neurosciences, Reproductive and Odontostomatological Sciences, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy.
Narayanaswami P; Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, United States.

Front Neurol ; 15: 1418631, 2024.

Article en En | MEDLINE | ID: mdl-38919972

Palabras clave

complement inhibitors; myasthenia gravis; neonatal Fc receptor antagonist; new treatments; rituximab; thymectomy; treatment strategy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Neurol Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google